Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3449) 3449
Newsletter (107) 107
Newspaper Article (44) 44
Book Chapter (19) 19
Magazine Article (7) 7
Conference Proceeding (3) 3
Dissertation (2) 2
Publication (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
abatacept (3266) 3266
science & technology (2491) 2491
life sciences & biomedicine (2425) 2425
humans (2048) 2048
animals (1440) 1440
ctla-4 antigen (1355) 1355
immunoconjugates (1332) 1332
antigens, cd (1100) 1100
immunology (996) 996
female (995) 995
mice (921) 921
male (918) 918
rheumatoid arthritis (720) 720
biological and medical sciences (701) 701
rheumatology (594) 594
immunoconjugates - therapeutic use (586) 586
t-lymphocytes - immunology (570) 570
medical sciences (549) 549
arthritis, rheumatoid - drug therapy (543) 543
abridged index medicus (537) 537
middle aged (528) 528
antirheumatic agents - therapeutic use (512) 512
adult (462) 462
immunosuppressive agents - therapeutic use (443) 443
treatment outcome (426) 426
antigens, differentiation - genetics (409) 409
transplantation (400) 400
lymphocyte activation (385) 385
antigens, differentiation - immunology (376) 376
t cells (339) 339
mice, inbred c57bl (333) 333
abatacept - therapeutic use (320) 320
aged (311) 311
mice, inbred balb c (306) 306
rheumatoid factor (304) 304
rituximab (294) 294
arthritis (290) 290
immunosuppressive agents - pharmacology (278) 278
surgery (271) 271
cd28 antigens - immunology (262) 262
rats (262) 262
antigens, differentiation - metabolism (255) 255
care and treatment (244) 244
research (240) 240
antibodies, monoclonal - therapeutic use (238) 238
fundamental and applied biological sciences. psychology (238) 238
b7-2 antigen (232) 232
analysis (228) 228
medicine, research & experimental (225) 225
research & experimental medicine (225) 225
graft rejection - prevention & control (217) 217
cells, cultured (216) 216
b7-1 antigen - immunology (212) 212
tumor necrosis factor-alpha - antagonists & inhibitors (212) 212
antigens, differentiation - physiology (209) 209
time factors (208) 208
antirheumatic agents - adverse effects (204) 204
immunoconjugates - pharmacology (203) 203
cd4-positive t-lymphocytes - immunology (199) 199
ctla-4 protein (196) 196
pharmacology. drug treatments (189) 189
immunoconjugates - adverse effects (187) 187
drug therapy (186) 186
transplantation, homologous (179) 179
graft rejection - immunology (173) 173
antigens, differentiation - pharmacology (169) 169
immunotherapy (168) 168
molecular sequence data (167) 167
cd28 antigens - metabolism (165) 165
fundamental immunology (163) 163
arthritis, rheumatoid - immunology (161) 161
kidney transplantation (160) 160
drug therapy, combination (158) 158
lymphocyte activation - immunology (158) 158
b7-1 antigen - metabolism (154) 154
ctla-4 (151) 151
methotrexate (151) 151
rats, inbred lew (150) 150
pharmacology & pharmacy (149) 149
immunosuppression (147) 147
chemical and pharmacologic phenomena (146) 146
lymphocytes (146) 146
flow cytometry (145) 145
t-lymphocytes - drug effects (145) 145
antibodies, monoclonal, humanized - therapeutic use (142) 142
immunoconjugates - administration & dosage (142) 142
graft survival - immunology (140) 140
musculoskeletal diseases (139) 139
cd28 antigens - physiology (137) 137
risk factors (136) 136
antibodies, monoclonal - pharmacology (134) 134
health aspects (134) 134
adolescent (133) 133
immunosuppressive agents - administration & dosage (132) 132
lymphocyte activation - drug effects (132) 132
infliximab (131) 131
antigens (130) 130
b7-1 antigen - physiology (130) 130
methotrexate - therapeutic use (129) 129
adalimumab (128) 128
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3470) 3470
Japanese (60) 60
French (44) 44
Spanish (32) 32
German (30) 30
Chinese (25) 25
Russian (11) 11
Portuguese (10) 10
Italian (7) 7
Czech (6) 6
Hungarian (5) 5
Polish (5) 5
Danish (3) 3
Korean (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Implementing a simple pharmacovigilance program to improve reporting of adverse events associated with biologic therapy in rheumatology: Preliminary results from the Calabria Biologics Pharmacovigilance Program (CBPP)
by Palleria, Caterina and Iannone, Luigi and Leporini, Christian and Citraro, Rita and Manti, Antonia and Caminiti, Maurizio and Gigliotti, Pietro and Grembiale, Rosa Daniela and L'Andolina, Massimo and Muccari, Giuseppe and Naturale, Maria Diana and Olivo, Domenico and Pagano Mariano, Giuseppa and Pellegrini, Roberta and Varcasia, Giuseppe and Abdalla, Karim and Russo, Emilio and Ursini, Francesco and De Sarro, Giovambattista
PloS one, 2018, Volume 13, Issue 10, p. e0205134
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Maintenance therapy for rheumatoid arthritis
by Panesar, Kiran
U.S. pharmacist, ISSN 0148-4818, 10/2011, Volume 36, Issue 10, pp. 60 - 68
Journal Article
Details down arrow
3. Full Text Neue Anti-B-Zell-Strategien fur die Therapie rheumatischer Erkrankungen
by Tarner, I.H
Zeitschrift für Rheumatologie, ISSN 0340-1855, 07/2009, Volume 68, Issue 5, p. 380
Abatacept
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Abatacept: A Review in Rheumatoid Arthritis
by Blair, Hannah A and Deeks, Emma D
Drugs (New York, N.Y.), ISSN 0012-6667, 07/2017, Volume 77, Issue 11, pp. 1221 - 1233
Pharmacology & Pharmacy | Toxicology | Life Sciences & Biomedicine | Science & Technology | Abatacept - pharmacology | Antirheumatic Agents - administration & dosage | Humans | Treatment Outcome | Clinical Trials as Topic | Methotrexate - therapeutic use | Methotrexate - adverse effects | Abatacept - adverse effects | Immunoconjugates - pharmacology | Arthritis, Rheumatoid - drug therapy | Abatacept - therapeutic use | Immunoconjugates - therapeutic use | Adult | Antirheumatic Agents - pharmacokinetics | Methotrexate - administration & dosage | Drug Therapy, Combination | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Antirheumatic Agents - therapeutic use | Intravenous administration | Pathogenesis | Clinical trials | Systematic review | Lymphocytes T | Arthritis | Proteins | Cell activation | Lymphocytes | Remission | Methotrexate | Fusion protein | Antigens | Signs and symptoms | Biological products | Rheumatology | T cell receptors | Patients | Immunogenicity | Tumor necrosis factor | Rheumatoid arthritis | Structural damage | TNF inhibitors | Cost analysis | Health risk assessment
Journal Article
Details down arrow
5. Full Text Abatacept for the treatment of systemic lupus erythematosus
by Pimentel-Quiroz, Victor R and Ugarte-Gil, Manuel F and Alarcón, Graciela S
Expert opinion on investigational drugs, ISSN 1354-3784, 04/2016, Volume 25, Issue 4, pp. 493 - 499
treatment | lupus nephritis | Systemic lupus erythematosus | abatacept | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Abatacept - pharmacology | Abatacept - adverse effects | Immunologic Factors - chemistry | Animals | Abatacept - therapeutic use | Humans | Lupus Erythematosus, Systemic - drug therapy | Abatacept - chemistry | Lupus Erythematosus, Systemic - metabolism | Immunologic Factors - adverse effects | Immunologic Factors - pharmacology | Immunologic Factors - therapeutic use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers
by Mercer, Louise K and Askling, Johan and Raaschou, Pauline and Dixon, William G and Dreyer, Lene and Hetland, Merete Lund and Strangfeld, Anja and Zink, Angela and Mariette, Xavier and Finckh, Axel and Canhao, Helena and Iannone, Florenzo and Zavada, Jakub and Morel, Jacques and Gottenberg, Jacques-Eric and Hyrich, Kimme L and Listing, Joachim
Annals of the rheumatic diseases, ISSN 0003-4967, 02/2017, Volume 76, Issue 2, pp. 386 - 391
Rheumatoid Arthritis | Anti-TNF | Epidemiology | Life Sciences & Biomedicine | Rheumatology | Science & Technology | Melanoma - epidemiology | Antibodies, Monoclonal, Humanized - therapeutic use | Humans | Middle Aged | Risk Factors | Europe - epidemiology | Male | Skin Neoplasms - epidemiology | Incidence | Rituximab - therapeutic use | Arthritis, Rheumatoid - drug therapy | Abatacept - therapeutic use | Aged, 80 and over | Adult | Female | Registries | Aged | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Antirheumatic Agents - therapeutic use | Biological Products - therapeutic use | Complications and side effects | Usage | Biological products | Tumor necrosis factor inhibitors | Rheumatoid arthritis | Risk factors | Skin cancer | Index Medicus | Clinical and Epidemiological Research | 1506 | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Belatacept and Long-Term Outcomes in Kidney Transplantation
by Vincenti, Flavio and Rostaing, Lionel and Grinyo, Joseph and Rice, Kim and Steinberg, Steven and Gaite, Luis and Moal, Marie-Christine and Mondragon-Ramirez, Guillermo A and Kothari, Jatin and Polinsky, Martin S and Meier-Kriesche, Herwig-Ulf and Munier, Stephane and Larsen, Christian P
The New England journal of medicine, ISSN 0028-4793, 01/2016, Volume 374, Issue 4, pp. 333 - 343
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Kidney Failure, Chronic - mortality | Single-Blind Method | Glomerular Filtration Rate | Kidney Failure, Chronic - surgery | Follow-Up Studies | Humans | Kaplan-Meier Estimate | Graft Survival | Abatacept - administration & dosage | Cyclosporine - therapeutic use | Abatacept - adverse effects | Cyclosporine - adverse effects | Intention to Treat Analysis | Immunosuppressive Agents - adverse effects | Kidney Transplantation - mortality | Immunosuppressive Agents - administration & dosage | Treatment outcome | Usage | Safety and security measures | Kidneys | Analysis | Organ transplant recipients | Belatacept | Dosage and administration | Transplantation | Health aspects | Immunosuppression | Renal function | Epidermal growth factor receptors | Transplants & implants | Cyclosporins | Immunotherapy | Survival | Patients | Clinical outcomes | Glomerular filtration rate | Kidney transplantation | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text T Cell–Mediated Rejection of Human CD34+ Cells Is Prevented by Costimulatory Blockade in a Xenograft Model
by Oh, Annie L and Mahmud, Dolores and Nicolini, Benedetta and Mahmud, Nadim and Senyuk, Vitalyi and Patel, Pritesh R and Bonetti, Elisa and Arpinati, Mario and Ferrara, James L.M and Rondelli, Damiano
Biology of blood and marrow transplantation, ISSN 1083-8791, 12/2017, Volume 23, Issue 12, pp. 2048 - 2056
Rejection | Stem cell transplantation | Abatacept | CD34 | T cell | Transplantation | Immunology | Life Sciences & Biomedicine | Hematology | Science & Technology | Abatacept - pharmacology | Antigens, CD34 | Reoperation | CD3 Complex | Graft Rejection - prevention & control | Humans | Graft Rejection - etiology | T-Lymphocytes - transplantation | Abatacept - administration & dosage | Animals | Heterografts | Time Factors | Abatacept - therapeutic use | Mice, Inbred NOD | T-Lymphocytes - immunology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study
by Pawar, Ajinkya and Desai, Rishi J and Solomon, Daniel H and Santiago Ortiz, Adrian J and Gale, Sara and Bao, Min and Sarsour, Khaled and Schneeweiss, Sebastian and Kim, Seoyoung C
Annals of the rheumatic diseases, ISSN 0003-4967, 04/2019, Volume 78, Issue 4, pp. 456 - 464
tumor necrosis factor inhibitor | tocilizumab | biologic therapy | serious infections | abatacept | bacterial infections | rheumatoid arthritis | Life Sciences & Biomedicine | Rheumatology | Science & Technology | Risk Assessment - methods | United States - epidemiology | Virus Diseases - epidemiology | Humans | Middle Aged | Hospitalization - statistics & numerical data | Male | Opportunistic Infections - chemically induced | Arthritis, Rheumatoid - drug therapy | Bacterial Infections - chemically induced | Antirheumatic Agents - adverse effects | Adult | Biological Products - adverse effects | Female | Antirheumatic Agents - therapeutic use | Biological Products - therapeutic use | Databases, Factual | Antibodies, Monoclonal, Humanized - adverse effects | Virus Diseases - chemically induced | Antibodies, Monoclonal, Humanized - therapeutic use | Opportunistic Infections - epidemiology | Comorbidity | Arthritis, Rheumatoid - epidemiology | Tumor Necrosis Factor Inhibitors - adverse effects | Abatacept - adverse effects | Abatacept - therapeutic use | Bacterial Infections - epidemiology | Aged | Cohort Studies | Studies | Bacterial infections | Tumor necrosis factor | Rheumatoid arthritis | Opportunist infection | Respiratory tract diseases | Tumor necrosis factor-TNF | Bacteria | Skin | Health risk assessment | Bacteremia | Tumors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text CD28 Costimulation: From Mechanism to Therapy
by Esensten, Jonathan H and Helou, Ynes A and Chopra, Gaurav and Weiss, Arthur and Bluestone, Jeffrey A
Immunity (Cambridge, Mass.), ISSN 1074-7613, 05/2016, Volume 44, Issue 5, pp. 973 - 988
Life Sciences & Biomedicine | Immunology | Science & Technology | Immunotherapy - methods | Receptor Cross-Talk | Receptors, Antigen, T-Cell - metabolism | Signal Transduction | Lymphocyte Activation | Humans | Autoimmune Diseases - immunology | Homeostasis | CD28 Antigens - immunology | Molecular Targeted Therapy | CD28 Antigens - metabolism | Autoimmune Diseases - genetics | Animals | CD28 Antigens - genetics | Abatacept - therapeutic use | Immunotherapy - trends | Autoimmune Diseases - therapy | T-Lymphocytes - immunology | Mice | CTLA-4 Antigen - antagonists & inhibitors | Epigenetic inheritance | Therapeutics | Family | Drug discovery | T cells | Homeopathy | Materia medica and therapeutics | Antigens | Phosphorylation | Disease | Cytokines | Lymphocytes | Rheumatoid arthritis | Mortality | Clinical trials | Ligands | T cell receptors | Laboratory animals | Gene expression | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights